The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial
Abstract
Background The Placement of Aortic Transcatheter Valves (PARTNER) trial showed that mortality at 1 year, 2 years, and 3 years is much the same with transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) for high-risk patients with aortic stenosis. We report here the 5-year outcomes.Methods We did this randomised controlled trial at 25 hospitals, in Canada (two), Germany (one), and the USA (23). We used a computer-generated randomisation sequence to randomly assign high-risk patients with severe aortic stenosis to either SAVR or TAVR with a balloon-expandable bovine pericardial tissue valve by either a transfemoral or transapical approach. Patients and their treating physicians were not masked to treatment allocation. The primary outcome of the trial was all-cause mortality in the intention-to-treat population at 1 year, we present here predefined outcomes at 5 years. The study is registered with ClinicalTrials.gov, number NCT00530894.Findings We screened 3105 patients, of whom 699 were enrolled (348 assigned to TAVR, 351 assigned to SAVR). Overall mean Society of Thoracic Surgeons Predicted Risk of Mortality score was 11·7%. At 5 years, risk of death was 67·8% in the TAVR group compared with 62·4% in the SAVR group (hazard ratio 1·04, 95% CI 0·86-1·24; p=0·76). We recorded no structural valve deterioration requiring surgical valve replacement in either group. Moderate or severe aortic regurgitation occurred in 40 (14%) of 280 patients in the TAVR group and two (1%) of 228 in the SAVR group (p<0·0001), and was associated with increased 5-year risk of mortality in the TAVR group (72·4% for moderate or severe aortic regurgitation vs 56·6% for those with mild aortic regurgitation or less; p=0·003).Interpretation Our findings show that TAVR as an alternative to surgery for patients with high surgical risk results in similar clinical outcomes.Funding Edwards Lifesciences.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For patients at high or prohibitive risk of operative mortality, with surgical AVR, TAVR has been a transformative innovation, providing a life-saving treatment for patients who were previously not candidates for AVR”
From Calcific aortic stenosis (2016) · cites this paper as [223]
Citations
Cites
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
Leon, M. B., Smith, C. R., Mack, M., Miller, D. C., Moses, J. W., Svensson, L. G., Tuzcu, E. M., Webb, J. G., Fontana, G. P., Makkar, R. R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008232 · Cited by 7,205
Self-citationTranscatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
Smith, C. R., Leon, M. B., Mack, M. J., Miller, D. C., Moses, J. W., Svensson, L. G., Tuzcu, E. M., Webb, J. G., Fontana, G. P., Makkar, R. R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103510 · Cited by 6,345
Self-citationTwo-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
Kodali, S. K., Williams, M. R., Smith, C. R., Svensson, L. G., Webb, J. G., Makkar, R. R., Fontana, G. P., Dewey, T. M., Thourani, V. H., Pichard, A. D., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200384 · Cited by 2,282
Self-citationTranscatheter Aortic-Valve Replacement for Inoperable Severe Aortic Stenosis
Makkar, R. R., Fontana, G. P., Jilaihawi, H., Kapadia, S., Pichard, A. D., Douglas, P. S., Thourani, V. H., Babaliaros, V. C., Webb, J. G., Herrmann, H. C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202277 · Cited by 1,342
Self-citationRegistry of Transcatheter Aortic-Valve Implantation in High-Risk Patients
Gilard, M., Eltchaninoff, H., Iung, B., Donzeau-Gouge, P., Chevreul, K., Fajadet, J., Leprince, P., Leguerrier, A., Lievre, M., Prat, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114705 · Cited by 1,228
Moat, N. E., Ludman, P., de Belder, M. A., Bridgewater, B., Cunningham, A. D., Young, C. P., Thomas, M., Kovac, J., Spyt, T., MacCarthy, P. A., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.050 · Cited by 884
Kapadia, S. R., Leon, M. B., Makkar, R. R., Tuzcu, E. M., Svensson, L. G., Kodali, S., Webb, J. G., Mack, M. J., Douglas, P. S., Thourani, V. H., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60290-2 · Cited by 867
Self-citationAthappan, G., Patvardhan, E., Tuzcu, E. M., Svensson, L. G., Lemos, P. A., Fraccaro, C., Tarantini, G., Sinning, J.-M., Nickenig, G., Capodanno, D., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.047 · Cited by 782
Self-citationVascular Complications After Transcatheter Aortic Valve Replacement
Généreux, P., Webb, J. G., Svensson, L. G., Kodali, S. K., Satler, L. F., Fearon, W. F., Davidson, C. J., Eisenhauer, A. C., Makkar, R. R., Bergman, G. W., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.003 · Cited by 518
Self-citationJilaihawi, H., Kashif, M., Fontana, G., Furugen, A., Shiota, T., Friede, G., Makhija, R., Doctor, N., Leon, M. B., & Makkar, R. R. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.11.045 · Cited by 480
Self-citation
Cited by
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Baumgartner, H., Falk, V., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Rodriguez Muñoz, D., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx391 · Cited by 6,243
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Metadata
- Authors
- Mack, M. J., Leon, M. B., Smith, C. R., Miller, D. C., Moses, J. W., Tuzcu, E. M., Webb, J. G., Douglas, P. S., Anderson, W. N., Blackstone, E. H., Kodali, S. K., Makkar, R. R., Fontana, G. P., Kapadia, S., Bavaria, J., Hahn, R. T., Thourani, V. H., Babaliaros, V., Pichard, A., Herrmann, H. C., Brown, D. L., Williams, M., Davidson, M. J., Svensson, L. G., & Akin, J.
- Affiliations
- Baylor Scott & White Health (US)
- NewYork–Presbyterian Hospital (US)
- Stanford Medicine (US)
- Cleveland Clinic (US)
- St. Paul's Hospital (CA)
- Duke Medical Center (US)
- Cedars-Sinai Medical Center (US)
- Lenox Hill Hospital (US)
- University of Pennsylvania (US)
- Emory University (US)
- MedStar Washington Hospital Center (US)
- Heart Hospital Baylor Plano (US)
- NYU Langone Health (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Mack, Michael J
- ORCID
- Mack, Michael J
- Leon, Martin B
- Smith, Craig R
- Miller, D Craig
- Moses, Jeffrey W
- Tuzcu, E Murat
- Webb, John G
- Douglas, Pamela S
- Anderson, William N
- Blackstone, Eugene H
- Kodali, Susheel K
- Makkar, Raj R
- Fontana, Gregory P
- Kapadia, Samir
- Bavaria, Joseph
- Hahn, Rebecca T
- Thourani, Vinod H
- Babaliaros, Vasilis
- Herrmann, Howard C
- Brown, David L
- Williams, Mathew
- Svensson, Lars G
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 385
- Issue
- 9986
- Pages
- 2477-2484
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2067905792
- Cited by
- 1,739
- References
- 31
- Citations by year
- 2026: 55 · 2025: 122 · 2024: 140 · 2023: 110 · 2022: 120 · 2021: 158 · 2020: 189 · 2019: 186 · 2018: 188 · 2017: 208 · 2016: 188 · 2015: 64
- FWCI
- 157.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Boston Scientific Corporation
- Medtronic
- Abbott Vascular
- St. Jude Medical
- National Heart, Lung, and Blood Institute (67025)
- Edwards Lifesciences
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Aortic Disease and Treatment Approaches
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- transcatheter aortic valve implantation, surgical aortic valve replacement, aortic stenosis, high-risk surgical patients, five-year outcomes, all-cause mortality, aortic regurgitation, transapical approach, transfemoral access, PARTNER trial, structural valve deterioration
- MeSH terms
- Aged, Aged, 80 and over, Aortic Valve, Aortic Valve Insufficiency, Aortic Valve Stenosis, Canada, Cause of Death, Female, Follow-Up Studies, Germany, Humans, Male, United States, Comorbidity, Survival Rate, Survival Analysis, Treatment Outcome, Heart Valve Prosthesis Implantation, Transcatheter Aortic Valve Replacement
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(15)60308-7
- The paper
- Mack, M. J., Leon, M. B., Smith, C. R., Miller, D. C., Moses, J. W., Tuzcu, E. M., Webb, J. G., Douglas, P. S., Anderson, W. N., Blackstone, E. H., Kodali, S. K., Makkar, R. R., Fontana, G. P., Kapadia, S., Bavaria, J., Hahn, R. T., Thourani, V. H., Babaliaros, V., Pichard, A., . . . Akin, J. (2015). 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(15)60308-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.